The University Hospital Zurich (USZ) is one of Europe’s leading academic medical centers, offering cutting-edge clinical care and internationally recognized diagnostic expertise. The Department of ...

As we look ahead to 2026, we are continuing to execute on our strategy with purpose and momentum to create value for all our stakeholders.” OTI’s rapid self-test for CT/NG is built on the Sherlock ...

OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...

New techniques and materials are spurring the development of next-generation molecular diagnostics, critical for disease prevention and treatment. Here we present emerging technologies and tools in ...

Over the last two years, the molecular diagnostics market has seen a handful of billion-dollar merger and acquisition deals, which have helped to expand and evolve the capabilities of larger companies ...

At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into ...

Disparities in delayed diagnosis, access to treatment, and treatment delays among Hispanic men with metastatic prostate cancer. Adjusted and unadjusted rates of use of molecular diagnostics and ...

In the realm of molecular diagnostics, new research highlights developments made by sequencing the DNA of pediatric cancer patients and links specific sequences to tumor risk. A perspective article ...

The "Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast ...

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.34 since the market last closed. This is a 6.09% ...

Last week, Insight Molecular Diagnostics Inc. ( NASDAQ:IMDX ) insiders, who had purchased shares in the previous ...